Correction: Parp mutations protect from mitochondrial toxicity in Alzheimer’s disease

Correction: Parp mutations protect from mitochondrial toxicity in Alzheimer’s disease

Bibliographic Details
Main Authors:	Yizhou Yu, Giorgio Fedele, Ivana Celardo, Samantha H. Y. Loh, L. Miguel Martins
Format:	Article
Language:	English
Published:	Nature Publishing Group 2021-07-01
Series:	Cell Death and Disease
Online Access:	https://doi.org/10.1038/s41419-021-03976-2

Similar Items

Parp mutations protect from mitochondrial toxicity in Alzheimer’s disease
by: Yizhou Yu, et al.
Published: (2021-06-01)

Combined Transcriptomic and Proteomic Analysis of Perk Toxicity Pathways
by: Rebeka Popovic, et al.
Published: (2021-04-01)

Mitochondrial Protection by PARP Inhibition
by: Ferenc Gallyas Jr, et al.
Published: (2020-04-01)

PARP INHIBITORS IN OVARIAN CANCER: TOXICITY PROFILE
by: S. V. KHOKHLOVA, et al.
Published: (2017-06-01)

PARP10 (ARTD10) modulates mitochondrial function.
by: Judit Márton, et al.
Published: (2018-01-01)

The role of PARP inhibitors in mutated pancreatic cancer
by: Jeffrey Chi, et al.
Published: (2021-05-01)

Cardiovascular Protective Effect of Metformin and Telmisartan: Reduction of PARP1 Activity via the AMPK-PARP1 Cascade.
by: Fenqing Shang, et al.
Published: (2016-01-01)

Dynamic Interplay between Copper Toxicity and Mitochondrial Dysfunction in Alzheimer’s Disease
by: Giusy Tassone, et al.
Published: (2021-04-01)

Combination of Selective PARP3 and PARP16 Inhibitory Analogues of Latonduine A Corrects F508del-CFTR Trafficking
by: Ryan M. Centko, et al.
Published: (2020-09-01)

Immunomodulatory Roles of PARP-1 and PARP-2: Impact on PARP-Centered Cancer Therapies
by: José Yélamos, et al.
Published: (2020-02-01)

First report on chlorophyllin to protect mammalian and fish muscle cells from pesticide toxicity via activation of p53 and PARP
by: Asmita Samadder, et al.
Published: (2021-07-01)

PARP Power: A Structural Perspective on PARP1, PARP2, and PARP3 in DNA Damage Repair and Nucleosome Remodelling
by: Lotte van Beek, et al.
Published: (2021-05-01)

Genome-wide and high-density CRISPR-Cas9 screens identify point mutations in PARP1 causing PARP inhibitor resistance
by: Stephen J. Pettitt, et al.
Published: (2018-05-01)

Antioxidants Protect against Arsenic Induced Mitochondrial Cardio-Toxicity
by: Clare Pace, et al.
Published: (2017-12-01)

Analysis of PARP inhibitor toxicity by multidimensional fluorescence microscopy reveals mechanisms of sensitivity and resistance
by: Jone Michelena, et al.
Published: (2018-07-01)

PARP inhibitors: review of mechanisms of action and BRCA1/2 mutation targeting
by: Karolina N. Dziadkowiec, et al.
Published: (2017-02-01)

PARP1 in Carcinomas and PARP1 Inhibitors as Antineoplastic Drugs
by: Luyao Wang, et al.
Published: (2017-10-01)

Correction: The BRCT Domain of PARP-1 Is Required for Immunoglobulin Gene Conversion.
by: Marcia N Paddock, et al.
Published: (2018-03-01)

Role of BRCA Mutations in Cancer Treatment with Poly(ADP-ribose) Polymerase (PARP) Inhibitors
by: Isabella Faraoni, et al.
Published: (2018-12-01)

Synergistic targeting of BRCA1 mutated breast cancers with PARP and CDK2 inhibition
by: Diar Aziz, et al.
Published: (2021-08-01)

Different regulation of PARP1, PARP2, PARP3 and TRPM2 genes expression in acute myeloid leukemia cells
by: Paulina Gil-Kulik, et al.
Published: (2020-05-01)

Forcing contacts between mitochondria and the endoplasmic reticulum extends lifespan in a Drosophila model of Alzheimer's disease
by: Juan Garrido-Maraver, et al.
Published: (2020-01-01)

Nucleolar PARP-1 Expression Is Decreased in Alzheimer’s Disease: Consequences for Epigenetic Regulation of rDNA and Cognition
by: Jianying Zeng, et al.
Published: (2016-01-01)

Mitochondrial DNA Depletion Reduces PARP-1 Levels and Promotes Progression of the Neoplastic Phenotype in Prostate Carcinoma
by: Loredana Moro, et al.
Published: (2008-01-01)

Serine-linked PARP1 auto-modification controls PARP inhibitor response
by: Evgeniia Prokhorova, et al.
Published: (2021-07-01)

ADP-ribosyltransferase PARP11 suppresses Zika virus in synergy with PARP12
by: Lili Li, et al.
Published: (2021-06-01)

Differential regulation of breast cancer bone metastasis by PARP1 and PARP2
by: Hao Zuo, et al.
Published: (2020-03-01)

PARP1 and PARP7 safeguard the lineage-specificity and pluripotency of ES cells
by: Roper, Stephen James
Published: (2011)

Design, Synthesis and Molecular Modeling Study of Conjugates of ADP and Morpholino Nucleosides as A Novel Class of Inhibitors of PARP-1, PARP-2 and PARP-3
by: Yuliya V. Sherstyuk, et al.
Published: (2019-12-01)

Protective Effect of Mitochondrial ND2 C5178A Gene Mutation on Cell and Mitochondrial Functions
by: Liuyang Tian, et al.
Published: (2021-01-01)

Assessment of Acrolein-induced Toxicity Using In-vitro Modeling to Evaluate the Role of PARP Inhibitors in Reducing Cytotoxicity
by: Harand, Kristina Marie
Published: (2016)

Correlation of homologous recombination deficiency induced mutational signatures with sensitivity to PARP inhibitors and cytotoxic agents
by: Ádám Póti, et al.
Published: (2019-11-01)

PARP Inhibitors as a Novel Treatment Strategy for Patients with BRCA-Mutated Metastatic Breast Cancer
by: Katarzyna Rygiel
Published: (2019-11-01)

Correction: How Statins May Protect against Alzheimer Disease.
Published: (2012-03-01)

Mitochondrial Drugs for Alzheimer Disease
by: Xiongwei Zhu, et al.
Published: (2009-12-01)

Combinations of PARP Inhibitors with Temozolomide Drive PARP1 Trapping and Apoptosis in Ewing's Sarcoma.
by: Sonja J Gill, et al.
Published: (2015-01-01)

Investigation of PARP-1, PARP-2, and PARG interactomes by affinity-purification mass spectrometry
by: Isabelle Maxim, et al.
Published: (2010-04-01)

Mitochondrial ubiquitin ligase alleviates Alzheimer’s disease pathology via blocking the toxic amyloid-β oligomer generation
by: Keisuke Takeda, et al.
Published: (2021-02-01)

Correction: Targeting EGFR Induced Oxidative Stress by PARP1 Inhibition in Glioblastoma Therapy
by: Masayuki Nitta, et al.
Published: (2011-01-01)

Correction: Targeting EGFR Induced Oxidative Stress by PARP1 Inhibition in Glioblastoma Therapy.
by: Masayuki Nitta, et al.
Published: (2011-01-01)

Cannot write session to /tmp/vufind_sessions/sess_3tquj6pdtblqe7c9c28328o0dh